EUVIMEDEUVIMED entdecken
Open Access

Investigating the Interaction between Excipients and Monoclonal Antibodies PGT121 and N49P9.6-FR-LS: A Comprehensive Analysis

Xun Li iD, Asuka A Orr iD, Mohammad M Sajadi, Anthony L DeVico, Daniel J Deredge iD, Alexander D MacKerell iD, Stephen W Hoag iD

Molecular Pharmaceutics · 07.04.2025 · 22 (4) · 1831-1846

DOI: 10.1021/acs.molpharmaceut.4c00973 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 03.03.2025. Verfasst von Xun Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Maryland Baltimore, Baltimore, Maryland 21201, United States. Hauptthemen laut MEDLINE: Excipients, Antibodies, Monoclonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N49P9.6-FR-LS and PGT121 are promising antibodies with significant therapeutic potential against HIV infection, but they are prone to precipitation at concentrations greater than 12 to 13 mg/mL. This study evaluates the influence of six excipients─arginine, alanine, sucrose, trehalose, methionine, and glutamate─on the biophysical stability of antibodies. We employed a comprehensive approach, combining computational mAb-excipient interaction analysis via the site-identification by ligand competitive saturation (SILCS) method with extensive experimental characterization. Our experimental matrix included viscosity measurements across temperature gradients, particle size distribution, zeta potential, pH value, and solution appearance, alongside a short-term stability product study at 30 °C and 65% relative humidity, with assessments at t0 (initial), t1 (14 days), and t2 (28 days). Results indicated that sucrose, arginine, alanine, and trehalose provided varying degrees of stabilization for both antibodies. Conversely, glutamate destabilized PGT121 but stabilized N49P9.6-FR-LS, while methionine had a negative effect on N49P9.6-FR-LS but a positive one on PGT121. SILCS-Biologics analysis suggested that stabilization by these excipients is linked to their ability to occupy regions involved in self-protein interactions. Debye-Hückel-Henry charge calculations further indicated that neutral excipients like sucrose and trehalose could alter mAb charges by affecting buffer binding, influencing aggregation propensity. These findings offer valuable insights for optimizing antibody formulations, ensuring enhanced product stability and therapeutic efficacy for HIV treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExcipientsAntibodies, MonoclonalViscosityTrehaloseSucroseParticle SizeHumansArginineDrug StabilityProtein Stability

Stichwörter der Autor:innen

Antibody stabilityExcipient-protein interactionHigh-concentration protein formulationProtein aggregationSILCS-Biologics

Substanzen

ExcipientsAntibodies, MonoclonalTrehaloseSucroseArginine

Autor:innen und Institutionen

  • School of Pharmacy, University of Maryland Baltimore, Baltimore, Maryland 21201, United States.
  • Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland 21201, United States.

ORCID-Profile: Xun Li, Asuka A Orr, Daniel J Deredge, Alexander D MacKerell, Stephen W Hoag

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • Bill and Melinda Gates Foundation
  • National Institute of Allergy and Infectious Diseases
  • National Institute of General Medical Sciences

Zitieren

APA

Li, X., Orr, A. A., Sajadi, M. M., DeVico, A. L., Deredge, D. J., MacKerell, A. D., & Hoag, S. W. (2025). Investigating the Interaction between Excipients and Monoclonal Antibodies PGT121 and N49P9.6-FR-LS: A Comprehensive Analysis. Molecular Pharmaceutics, 22(4), 1831-1846. https://doi.org/10.1021/acs.molpharmaceut.4c00973

Vancouver

Li X, Orr AA, Sajadi MM, DeVico AL, Deredge DJ, MacKerell AD, et al. Investigating the Interaction between Excipients and Monoclonal Antibodies PGT121 and N49P9.6-FR-LS: A Comprehensive Analysis. Molecular Pharmaceutics. 2025;22(4):1831-1846. doi:10.1021/acs.molpharmaceut.4c00973

BibTeX
@article{Li2025,
  author = {Li, Xun and Orr, Asuka A and Sajadi, Mohammad M and DeVico, Anthony L and Deredge, Daniel J and MacKerell, Alexander D and Hoag, Stephen W},
  title = {Investigating the Interaction between Excipients and Monoclonal Antibodies PGT121 and N49P9.6-FR-LS: A Comprehensive Analysis},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {4},
  pages = {1831--1846},
  doi = {10.1021/acs.molpharmaceut.4c00973}
}
Kostenlos starten →